Latest filing published 04 Jun 2021 for Ironwood Pharmaceuticals INC.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +10.8%Entry US$9.97 · Close at T+365 US$11.05
- +12.2%Entry US$9.59 · Close at T+365 US$10.76
- +73.8%Entry US$8.08 · Close at T+365 US$14.05
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Edward P. Owens: trading record in brief
All filings by Edward P. Owens on record concern Ironwood Pharmaceuticals Inc, in the capacity of board member. The record holds 16 filings, for trades running from 1 March 2013 to 2 June 2021.
Purchases make up the whole of the open-market record (4 purchases, €188k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 10 share grants. 2021 to date brings 3 purchases and no sales.
A typical purchase (the median) is worth €45k. 1 out of 4 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. Ninety days after publication, 4 purchases show a median change of +20.6%, with the price up in 100% of them. This is a record of the past, not a forecast.
The newest entry dates from 4 June 2021: a share grant, in Ironwood Pharmaceuticals Inc. The latest purchase dates back some time: it was published 2,078 days ago, on 2 March 2021. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Edward P. Owens
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 22,766 shares0Class A Common StockSEC:0001209191-21-038218:0
- 3,000 shares@ US$8.9011.7% of flowClass A Common StockSEC:0001209191-21-016082:0Canonical exit: 27 May 2021 (T+90)
- 7,000 shares@ US$9.2628.3% of flowClass A Common StockSEC:0001209191-21-014866:0Canonical exit: 25 May 2021 (T+90)
- 5,000 shares@ US$9.1119.9% of flowClass A Common StockSEC:0001209191-21-014866:1Canonical exit: 26 May 2021 (T+90)
- 21,720 shares0Class A Common StockSEC:0001209191-20-034700:0
- 22,706 shares0Class A Common StockSEC:0001209191-19-033645:0
- 40,000 shares0Class A Common StockSEC:0001209191-18-048406:0
- 40,000 shares0Class A Common StockSEC:0001209191-18-048406:1
- 16,223 shares0Class A Common StockSEC:0001209191-18-035250:0
- 15,625 shares0Class A Common StockSEC:0001209191-17-037355:0
- 23,674 shares0Class A Common StockSEC:0001209191-16-125650:0
- 10,000 shares@ US$8.32100.0% of flowClass A Common StockSEC:0001209191-16-102915:0Canonical exit: 24 May 2016 (T+90)
- 16,556 shares0Class A Common StockSEC:0001209191-15-050413:0
- 19,778 shares0Class A Common StockSEC:0001209191-14-039313:0
- 9,339 shares0Class A Common StockSEC:0001209191-14-001085:0
- 8,333 shares0Class A Common StockSEC:0001209191-13-013914:0
16 of 16 declarations
